Issue 37, 2014

Presentation of HER2 epitopes using a filamentous plant virus-based vaccination platform

Abstract

Human epidermal growth factor receptor 2 (HER2)-positive cancers are aggressive, have poor prognoses, and have a high rate of metastasis and relapse. Immunotherapy (e.g. trastuzumab) has shown improvement in the outcome for HER2 patients. Development of drug resistance and short half-lives limiting the duration of the therapy are barriers in the development of effective therapeutic strategies. Furthermore, while passive immunotherapy provides treatment, it does not reduce the risk of recurrence of the disease. These barriers have fueled the development of active immunotherapies using HER2 vaccines. We turned toward the development of a nanoparticle-based peptide vaccine. Specifically, we integrated HER2 epitopes on the plant-produced vaccination platform potato virus X (PVX) to overcome immunological tolerance against HER2. The carrier acts as an adjuvant and improves stability and B cell presentation of the epitopes. Immunizations of FVB/N mice resulted in the production of HER2-specific antibodies, as shown by ELISA and confocal microscopy using HER2-positive human cancer cell lines.

Graphical abstract: Presentation of HER2 epitopes using a filamentous plant virus-based vaccination platform

Article information

Article type
Paper
Submitted
09 Mai 2014
Accepted
31 Quint 2014
First published
04 Sext 2014

J. Mater. Chem. B, 2014,2, 6249-6258

Presentation of HER2 epitopes using a filamentous plant virus-based vaccination platform

S. Shukla, A. M. Wen, U. Commandeur and N. F. Steinmetz, J. Mater. Chem. B, 2014, 2, 6249 DOI: 10.1039/C4TB00749B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements